Literature DB >> 22461158

The "osteoporosis disease".

Giulio Guido1, Michelangelo Scaglione, Luca Fabbri, Michele James Ceglia.   

Abstract

The authors analyze the reason that make osteoporosis a complex, widespread and poorly controlled "disease". In their work the authors take into account etiopathogenesis, epidemiology, risk factors, diagnosis and therapy. Author's attention is focused on management both of patient whit osteoporotic fractures and preventive therapy, which are aspects of the osteoporotic desease that should not be exclusive problems for the orthopaedic's sourgeon.

Entities:  

Year:  2009        PMID: 22461158      PMCID: PMC2781223     

Source DB:  PubMed          Journal:  Clin Cases Miner Bone Metab        ISSN: 1724-8914


  4 in total

1.  Early identification of children predisposed to low peak bone mass and osteoporosis later in life.

Authors:  M L Loro; J Sayre; T F Roe; M I Goran; F R Kaufman; V Gilsanz
Journal:  J Clin Endocrinol Metab       Date:  2000-10       Impact factor: 5.958

2.  Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation.

Authors:  S Nishida; N Endo; H Yamagiwa; T Tanizawa; H E Takahashi
Journal:  J Bone Miner Metab       Date:  1999       Impact factor: 2.626

3.  Mortality after osteoporotic fractures.

Authors:  O Johnell; J A Kanis; A Odén; I Sernbo; I Redlund-Johnell; C Petterson; C De Laet; B Jönsson
Journal:  Osteoporos Int       Date:  2003-10-30       Impact factor: 4.507

Review 4.  European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Authors:  J A Kanis; N Burlet; C Cooper; P D Delmas; J-Y Reginster; F Borgstrom; R Rizzoli
Journal:  Osteoporos Int       Date:  2008-02-12       Impact factor: 4.507

  4 in total
  6 in total

1.  The second hip fracture in osteoporotic patients: not only an orthopaedic matter.

Authors:  Michelangelo Scaglione; Luca Fabbri; Federica Di Rollo; Maria Giulia Bianchi; Dario Dell'omo; Giulio Guido
Journal:  Clin Cases Miner Bone Metab       Date:  2013-05

Review 2.  Fructus Ligustri Lucidi in Osteoporosis: A Review of its Pharmacology, Phytochemistry, Pharmacokinetics and Safety.

Authors:  Beibei Chen; Lili Wang; Lin Li; Ruyuan Zhu; Haixia Liu; Chenyue Liu; Rufeng Ma; Qiangqiang Jia; Dandan Zhao; Jianzhao Niu; Min Fu; Sihua Gao; Dongwei Zhang
Journal:  Molecules       Date:  2017-09-05       Impact factor: 4.411

3.  Evaluation of Dexamethasone-Induced Osteoporosis In Vivo Using Zebrafish Scales.

Authors:  Siripat Chaichit; Takuto Sato; Huiqing Yu; Yu-Ki Tanaka; Yasumitsu Ogra; Takamasa Mizoguchi; Motoyuki Itoh
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-03

4.  Hafnium (IV) oxide obtained by atomic layer deposition (ALD) technology promotes early osteogenesis via activation of Runx2-OPN-mir21A axis while inhibits osteoclasts activity.

Authors:  A Seweryn; M Alicka; A Fal; K Kornicka-Garbowska; K Lawniczak-Jablonska; M Ozga; P Kuzmiuk; M Godlewski; K Marycz
Journal:  J Nanobiotechnology       Date:  2020-09-15       Impact factor: 10.435

Review 5.  The Paradoxical Role of Uric Acid in Osteoporosis.

Authors:  Kun-Mo Lin; Chien-Lin Lu; Kuo-Chin Hung; Pei-Chen Wu; Chi-Feng Pan; Chih-Jen Wu; Ren-Si Syu; Jin-Shuen Chen; Po-Jen Hsiao; Kuo-Cheng Lu
Journal:  Nutrients       Date:  2019-09-05       Impact factor: 5.717

6.  Geniposide Ameliorated Dexamethasone-Induced Cholesterol Accumulation in Osteoblasts by Mediating the GLP-1R/ABCA1 Axis.

Authors:  Yizhou Zheng; Yaosheng Xiao; Di Zhang; Shanshan Zhang; Jing Ouyang; Linfu Li; Weimei Shi; Rui Zhang; Hai Liu; Qi Jin; Zhixi Chen; Daohua Xu; Longhuo Wu
Journal:  Cells       Date:  2021-12-06       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.